Know Cancer

or
forgot password

Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle


Phase 2
16 Years
N/A
Open (Enrolling)
Both
Sarcoma of Pelvis

Thank you

Trial Information

Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle


Inclusion Criteria:



- Soft tissue or bone sarcomas locally advanced of the pelvis or limbs’ girdle

Exclusion Criteria:

- Resectable tumor without mutilation

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Complete response rate on MRI

Principal Investigator

Sylvie Bonvalot, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Gustave Roussy, Cancer Campus, Grand Paris

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

PIP

NCT ID:

NCT00181025

Start Date:

May 2004

Completion Date:

Related Keywords:

  • Sarcoma of Pelvis
  • Limbs’ girdle
  • Sarcoma

Name

Location